{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-040329","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2026-08-27T12:30:22+00:00","discovered_at":"2026-08-27T12:35:00.391344+00:00","generated_at":"2026-08-27T12:35:23.896503+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Interpace Biosciences announces 1-for-5 reverse stock split to support Nasdaq uplisting","bullets":["1-for-5 reverse stock split effective 12:01 a.m. ET Aug 27, 2026; shares reduced from ~27.7M to ~5.5M.","Ticker temporarily changes to IDXGD for 20 trading days; new CUSIP 46062X402; par value unchanged at $0.01.","Split intended to meet Nasdaq minimum bid price requirement; company also needs $15M market value of unrestricted public shares.","Proportional adjustments to outstanding stock options, RSUs, and equity plan shares; fractional shares rounded up.","CEO Tom Burnell: split is key part of strategy to uplist to Nasdaq and attract broader investor base."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-040329","json":"https://secwatch.observer/filing/0001493152-26-040329.json","markdown":"https://secwatch.observer/filing/0001493152-26-040329.md","text":"https://secwatch.observer/filing/0001493152-26-040329.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226040329/0001493152-26-040329-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226040329/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-27T12:35:23.896503+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}